Robert W. Baird raises target for Intuitive Surgical stock to USD 550.00
Published on 10/27/2026 at 18:29 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSAnalyst target and quarterly growth
- Robert W. Baird raised its Intuitive Surgical target from USD 513.00 to USD 550.00 on October 21, 2026.
- Third-quarter revenue reached USD 3.05 billion on October 20, 2026, up 22.00 percent from the prior-year quarter.
- Intuitive Surgical stock costs EUR 400.33 at Lang & Schwarz on October 27, 2026 at 6:24 p.m. CEST.
- The Nasdaq-listed company had a USD 157.6 billion market capitalization and a 53.56 P/E ratio as of October 27, 2026.
Intuitive Surgical (ISIN US46120E6023) is drawing attention to a new USD 550.00 price target after MarketBeat reported on October 21, 2026 that Robert W. Baird raised its target from USD 513.00 to USD 550.00 and kept an Outperform rating. Intuitive Surgical was trading at EUR 400.33 at Lang & Schwarz on October 27, 2026 at 6:24 p.m. CEST.
Revenue growth meets a legal charge
For the third quarter ended September 30, 2026, revenue reached USD 3.05 billion, an increase of 22.00 percent from USD 2.51 billion a year earlier, according to Intuitive Surgical on October 20, 2026. Non-GAAP net income rose to USD 1.05 billion, or USD 3.00 per diluted share, from USD 867.00 million, or USD 2.40, while GAAP net income fell to USD 522.80 million after a USD 450.00 million pretax litigation charge.
Nasdaq range remains wide
The Nasdaq quote was USD 446.16 at 1:28 p.m. ET on October 27, 2026. The same quotation carried a 52-week range of USD 328.57 to USD 603.88, placing the stock USD 157.72 above its low and USD 157.72 below its high only as a direct level comparison in the same currency. Its market capitalization was USD 157.6 billion.
What does the target imply?
Robert W. Baird's USD 550.00 target stood 23.28 percent above the USD 446.16 Nasdaq price on October 27, 2026. That comparison places the analyst view alongside the latest operating figures rather than treating the target as a forecast by this article.
Comparison with peers
Intuitive Surgical: P/E 53.56, market capitalization USD 157.6 billion. Stryker Corporation: P/E 31.28, market capitalization USD 115.8 billion. Medtronic: P/E 23.21, market capitalization USD 120.6 billion. The peer figures were dated October 27, 2026 at 1:28 p.m. ET.
Price and company snapshot
Intuitive Surgical combines a 22.00 percent year-over-year revenue increase with a litigation charge that reduced GAAP earnings in the third quarter. The company also placed 546 da Vinci systems during the quarter, compared with 427 in the prior-year period.
The further course of trading is shown by the continuously updated real-time quote of Intuitive Surgical stock.
Key stock data
- Company: Intuitive Surgical, Inc.
- ISIN: US46120E6023
- Ticker: ISRG
- Primary exchange: Nasdaq
- Price Lang & Schwarz (as of October 27, 2026, 6:24 p.m. CEST): EUR 400.33
- Market capitalization: USD 157.6 billion (as of October 27, 2026)
- 52-week range: USD 328.57-603.88 (as of October 27, 2026)
- Sector / Industry: Healthcare / Medical Instruments and Supplies
Market context: Market report S&P 500.
